Immunotherapy for Blood Cancer

Acute Lymphoblastic Leukemia

Immunotherapy aims at identification of immature cells in ALL to fight this rapidly proliferative cancer

Chronic Lymphocytic Leukemia

In this case, immunotherapy is effective in regulating the slow nature of the cancer and the immune response to the cancer cells

Acute Myeloid Leukemia

A new approach to cancer treatment in AML by targeting the leukemia cells, thus, augmenting the prognosis of this aggressive cancer

Chronic Myeloid Leukemia

Assists in maintaining the patient’s health for the remaining part by recognize and eradicate the cancer cells

Hodgkin Lymphoma

Plays a key role in assisting the immune system to identify and obliterate plasma cells proficiently  

Non-Hodgkin Lymphoma

It increases the capacity of the body immune system to mark and combat the spread of lymphoma cells

Multiple Myeloma

It is aimed identify and target the malignant plasma cells that characterize the disease to provide an effective treatment